In this study, we investigated the therapeutic potential of
Cinnamomum camphora
leaves on allergic skin inflammation such as atopic dermatitis. We evaluated the effects of
C. camphora
leaves on human adult low-calcium high-temperature keratinocytes and atopic dermatitis mice.
C. camphora
leaves inhibited Macrophage-derived chemokine (an inflammatory chemokine) production in interferon-γ (10 ng/mL) stimulated Human adult low-calcium high-temperature keratinocytes in a dose dependent manner.
C. camphora
leaves suppressed the phosphorylation of janus kinase signal transducer and activator of transcription 1.
C. camphora
leaves also suppressed the phosphorylation of extracellular signal-regulated kinase 1/2, a central signaling molecule in the inflammation process. These results suggest that
C. camphora
leaves exhibits anti-inflammatory effect via the phosphorylation of signal transducer and activator of transcription 1 and extracellular signal-regulated kinase 1/2. To study the advanced effects of
C. camphora
leaves on atopic dermatitis, we induced experimental atopic dermatitis in mice by applying 2,4-dinitrochlorobenzene. The group treated with
C. camphora
leaves (100 mg/kg) showed remarkable improvement of atopic dermatitis symptoms: reduced serum immunoglobulin E levels, smaller lymph nodes with reduced thickness and length, decreased ear edema, and reduced levels of inflammatory cell infiltration in the ears. Interestingly, the effects of
C. camphora
leaves on atopic dermatitis symptoms were stronger than those of hydrocort cream, a positive control. Taken together,
C. camphora
leaves showed alleviating effects on the inflammatory chemokine production
in vitro
and atopic dermatitis symptoms
in vivo
. These results suggest that
C. camphora
leaves help in the treatment of allergic inflammation such as atopic dermatitis.